MIRA
INFORM REPORT
|
Report Date : |
19.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
OKASA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
12, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
19.04.1933 |
|
|
|
|
Com. Reg. No.: |
001957 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.53.162 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239MH1933PTC001957 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMO02992D |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAAC00677L |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufactures and Distributes pharmaceutical products in
core therapeutic categories including medicinal aerosols and devices, oncology
products, antiretrovirals, cardiovascular drugs, anti-infectives,
antifungals, antiallergics, dermatologicals, drugs for pain management and
psychotherapeutics. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (49) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 2643772 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. There
appears dip in the profitability. Trade relations are reported as fair.
Business is active. Payments are reported to be regular and as per
commitments. The company can be considered for normal business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.09.2011) |
Current Rating (31.12.2011) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
12, Gunbow Street, Hornby View Building, Mumbai – 400001, Maharashtra,
India |
|
Tel. No.: |
91-22-22611206 |
|
Fax No.: |
91-22-22659376 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
AS ON 30.09.2011
|
Name : |
Mr. A P Raman |
|
Designation : |
Director |
|
Address : |
Flat No.202, Pride, J B Road, Versova, Mumbai – 400061, Maharashtra,
Idnia |
|
Date of Birth/Age : |
15.12.1953 |
|
Date of Appointment : |
05.06.2002 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name of the Company/ LLP |
Current designation of the
Director/ Designated Partner |
Date of appointment at
current designation |
Original date of appointment |
Date of cessation |
Company/ LLP Status |
Defaulting status |
|
1 |
U33125MH1991PTC063124 |
HAMSONS LABORATORIES
PRIVATE LIMITED |
Director |
06/08/1992 |
06/08/1992 |
- |
Active |
NO |
|
2 |
U24100MH1985PTC035750 |
SHREE RIDDHI CHEMICALS PVT
LTD |
Director |
18/03/1994 |
18/03/1994 |
- |
Active |
NO |
|
3 |
U18101MH1984PTC034912 |
MN RAJKUMAR GARMENTS PVT
LTD |
Director |
18/03/1994 |
18/03/1994 |
- |
Active |
NO |
|
4 |
U27239MH1985PTC037680 |
ALPIC REMEDIES PRIVATE
LIMITED |
Director |
18/03/1994 |
18/03/1994 |
- |
Active |
NO |
|
5 |
U24110MH1990PTC056055 |
SAGA CHEMICALS PRIVATE
LIMITED |
Director |
09/09/1994 |
09/09/1994 |
25/06/2011 |
Active |
NO |
|
6 |
U99999MH1992PTC065449 |
PREMRATAN EXPORTS PVT LTD |
Director |
01/03/1995 |
01/03/1995 |
25/06/2011 |
Active |
NO |
|
7 |
U51900MH1996PTC101545 |
CENTAUR EXPORTS PRIVATE
LIMITED |
Director |
06/12/1996 |
06/12/1996 |
- |
Amalgamated |
NO |
|
8 |
U01111MH1995PTC094271 |
FLORAL FANTASY PRIVATE
LIMITED |
Director |
22/03/1997 |
22/03/1997 |
- |
Active |
NO |
|
9 |
U70100MH1988PTC047485 |
HAMCON ENGINEERS PRIVATE
LIMITED |
Director |
15/10/1997 |
15/10/1997 |
- |
Active |
NO |
|
10 |
U65920MH1985PTC037699 |
IRIS PROPERTIES PRIVATE
LIMITED |
Director |
17/10/1997 |
17/10/1997 |
- |
Amalgamated |
NO |
|
11 |
U24234MH2000PTC125743 |
CIPLA NATURAL SCIENCES
PRIVATE LIMITED |
Director |
01/06/2000 |
01/06/2000 |
- |
Active |
NO |
|
12 |
U24230MH2000PTC125757 |
ORION LIFE SCIENCES
PRIVATE LIMITED |
Director |
01/06/2000 |
01/06/2000 |
- |
Active |
NO |
|
13 |
U24230MH2000PTC125771 |
FOREST GOLD PRODUCTS
PRIVATE LIMITED |
Director |
01/06/2000 |
01/06/2000 |
- |
Active |
NO |
|
14 |
U24234MH2000PTC125744 |
OKASA GENERICS PRIVATE
LIMITED |
Director |
01/06/2000 |
01/06/2000 |
- |
Active |
NO |
|
15 |
U72200MH2000PTC125580 |
E-MAN CONSULTANTS PRIVATE
LIMITED |
Director |
06/01/2001 |
06/01/2001 |
- |
Amalgamated |
NO |
|
16 |
U24239MH2000PTC123771 |
HEALINGCROSS PHARMA
PRIVATE LIMITED |
Director |
28/03/2002 |
28/03/2002 |
- |
Active |
NO |
|
17 |
U24239MH1933PTC001957 |
OKASA PRIVATE LIMITED |
Managing director |
05/06/2002 |
05/06/2002 |
- |
Active |
NO |
|
18 |
U51900MH1997PTC109987 |
L'AMAR EXPORTS PRIVATE
LIMITED |
Director |
01/10/2002 |
01/10/2002 |
03/05/2011 |
Active |
NO |
|
19 |
U24230MH1988PTC047593 |
OMNICARE SPECIALITIES
PRIVATE LIMITED |
Director |
01/12/2003 |
01/12/2003 |
- |
Active |
NO |
|
20 |
U24231KA2005PTC037008 |
AVESTA BIOTHERAPEUTICS AND
RESEARCH PRIVATE LIMITED |
Director |
18/08/2005 |
18/08/2005 |
01/10/2008 |
Active |
NO |
|
21 |
U24230MH2005PTC150847 |
NEPTUNE REMEDIES PRIVATE
LIMITED |
Director |
30/12/2005 |
30/12/2005 |
- |
Amalgamated |
NO |
|
22 |
U24230MH2005PTC153054 |
SYNERGY MEDICINES PRIVATE
LIMITED |
Director |
13/01/2006 |
13/01/2006 |
- |
Active |
NO |
|
23 |
U24240MH2000PTC129213 |
RESPAIR TECHNOLOGIES INDIA
PRIVATE LIMITED |
Director |
01/03/2006 |
01/03/2006 |
02/05/2007 |
Active |
NO |
|
24 |
U24239MH2000PTC130004 |
UNI WORLD PHARMA PRIVATE
LIMITED |
Director |
01/03/2006 |
01/03/2006 |
- |
Active |
NO |
|
25 |
U24239MH2000PTC126345 |
DNA PHARMA PRIVATE LIMITED
|
Director |
01/03/2006 |
01/03/2006 |
- |
Active |
NO |
|
26 |
U24230MH2000PTC126487 |
MEDICREAMS INDIA PRIVATE
LIMITED |
Director |
02/05/2007 |
02/05/2007 |
- |
Active |
NO |
|
27 |
U51909MH2005PTC153506 |
DREAMZ IMPEX PRIVATE
LIMITED |
Director |
02/05/2007 |
02/05/2007 |
- |
Active |
NO |
|
28 |
U24239MH2008PTC185974 |
MABPHARM PRIVATE LIMITED |
Director |
20/08/2008 |
20/08/2008 |
- |
Active |
NO |
|
29 |
U74900PN2010PTC135799 |
LABH CONSULTANTS PRIVATE
LIMITED |
Director |
17/03/2010 |
17/03/2010 |
- |
Active |
NO |
|
30 |
U24239MH2006PLC162743 |
GLOBUS HEALTHCARE LIMITED |
Director |
30/09/2010 |
15/04/2010 |
- |
Active |
NO |
|
31 |
U24230MH2000PTC125770 |
CIPLA LIFE SCIENCES
PRIVATE LIMITED |
Additional director |
04/11/2011 |
04/11/2011 |
- |
Active |
NO |
|
Name : |
Mr. S N Salgaon |
|
Designation : |
Director |
|
Address : |
14, Khadpaband, Flat No. T-1, Ponda, Goa – 403401, India |
|
Date of Birth/Age : |
31.12.1949 |
|
Date of Appointment : |
08.06.2002 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name of the Company/ LLP |
Current designation of the
Director/ Designated Partner |
Date of appointment at
current designation |
Original date of
appointment |
Date of cessation |
Company/ LLP Status |
Defaulting status |
|
1 |
U24230MH2000PTC126487 |
MEDICREAMS INDIA PRIVATE
LIMITED |
Director |
01/06/2000 |
01/06/2000 |
02/05/2007 |
Active |
NO |
|
2 |
U24230MH1988PTC047035 |
MEDEX SPECIALITIES PRIVATE
LIMITED |
Director |
28/03/2002 |
28/03/2002 |
- |
Active |
NO |
|
3 |
U24239MH1933PTC001957 |
OKASA PRIVATE LIMITED |
Director |
08/06/2002 |
08/06/2002 |
- |
Active |
NO |
|
4 |
U73100MH2000PTC127290 |
CIPLA RESEARCH CENTRE
PRIVATE LIMITED |
Director |
18/09/2002 |
18/09/2002 |
- |
Active |
NO |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.09.2011
|
Names of Shareholders |
|
No. of Shares |
|
Ahmed Sophie |
|
6840 |
|
Ahmed Monisha |
|
744 |
|
Ahmed Farah |
|
744 |
|
Ahmed Sarah |
|
744 |
|
Khire Vilas Gopal |
|
800 |
|
Saga Chemicals Private Limited, Mumbai |
|
80000 |
|
Meera Raman |
|
6550 |
|
A P Raman |
|
1200 |
|
Usmani Wahid |
|
8000 |
|
Hamsons Labs Private Limited, Mumbai
|
|
155828 |
|
Jaya Radhakrishnan |
|
6750 |
|
S N Salgaonkar |
|
500 |
|
Paramjit Kaur |
|
6750 |
|
Shree Ridhi Chemicals Private Limited, Mumbai |
|
100000 |
|
Floral Fantasy Private Limited, Mumbai |
|
83550 |
|
Respair Technology Private Limited, Mumbai |
|
32000 |
|
Prem Remedies Private Limited, Mumbai |
|
30000 |
|
Globus Healthcare Limited, Mumbai |
|
10635 |
AS ON 30.09.2011
|
Category |
Percentage |
|
Directors or relatives of Directors |
1.55 |
|
Other |
98.45 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufactures and Distributes pharmaceutical products in
core therapeutic categories including medicinal aerosols and devices, oncology
products, antiretrovirals, cardiovascular drugs, anti-infectives,
antifungals, antiallergics, dermatologicals, drugs for pain management and
psychotherapeutics. |
PRODUCTION STATUS AS ON 31.03.2011
|
Particulars |
Unit |
|
Installed
Capacity |
Actual
Production |
|
Tablets and Capsules |
Millions |
|
585.00 |
188.67 |
|
Dry Syrup |
Tonne |
|
210.00 |
176.88 |
|
Dry Powder Injectable |
Tonne |
|
7.58 |
0.000 |
|
Liquid Orals |
Kilolitre |
|
360.00 |
173.63 |
|
Creams |
Tonne |
|
0.000 |
106.91 |
|
Injections |
Kilolitre |
|
0.000 |
25.80 |
|
Aerosols / Inhalation Devices |
Thousand |
|
0.000 |
261.48 |
|
Bulk Drugs |
Tonne |
|
0.000 |
2.82 |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|||||||||
|
|
|
|||||||||
|
Bankers : |
Not Available |
|||||||||
|
|
|
|||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
R S Bharucha and Company Chartered Accountant |
|
Address : |
Jehangir Mansion, 1st Marine Street, Mumbai 400020, Maharashtra, India
|
|
|
|
|
Fellow Subsidiaries : |
·
Okasa Generics Private Limited ·
Okasa Pharman Private Limited |
CAPITAL STRUCTURE
AS ON 30.09.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1000000 |
Equity Shares |
Rs.100/- each |
Rs.100.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
531625 |
Equity Shares |
Rs.100/-
each |
Rs.53.162
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
53.162 |
52.100 |
52.100 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
607.781 |
574.493 |
613.200 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
660.943 |
626.593 |
665.300 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.073 |
2.304 |
6.679 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
0.073 |
2.304 |
6.679 |
|
|
DEFERRED TAX LIABILITIES |
1.167 |
1.549 |
2.203 |
|
|
|
|
|
|
|
|
TOTAL |
662.183 |
630.446 |
674.182 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
98.338 |
106.029 |
121.919 |
|
|
Capital work-in-progress |
1.524 |
2.609 |
0.809 |
|
|
|
|
|
|
|
|
INVESTMENT |
521.335 |
251.129 |
278.438 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
83.679
|
120.689 |
101.935 |
|
|
Sundry Debtors |
193.570
|
96.702 |
152.150 |
|
|
Cash & Bank Balances |
15.420
|
89.975 |
15.173 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
701.964
|
658.615 |
791.385 |
|
Total
Current Assets |
994.633
|
965.981 |
1060.643 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
258.503
|
182.126 |
|
|
|
Other Current Liabilities |
296.262
|
317.247 |
|
|
|
Provisions |
398.883
|
195.929 |
247.658 |
|
Total
Current Liabilities |
953.648
|
695.302 |
787.627 |
|
|
Net Current Assets |
40.986
|
270.679 |
273.016 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
662.183 |
630.446 |
674.182 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
TOTAL |
791.457 |
814.085 |
1294.425 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
TOTAL
|
NA |
NA |
NA |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
82.414 |
173.138 |
229.181 |
|
|
|
|
|
|
|
|
|
|
DEPRECIATION/
AMORTISATION |
13.635 |
15.115 |
17.670 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
NA |
NA |
NA |
|
|
|
|
|
|
|
|
|
|
TAX |
22.847 |
48.000 |
54.500 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX |
46.315 |
110.676 |
157.661 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
111.453 |
164.059 |
266.016 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
5.100 |
11.400 |
15.800 |
|
|
|
Tax on Dividend |
3.450 |
21.633 |
208.400 |
|
|
|
Interim Dividend |
21.265 |
130.250 |
35.418 |
|
|
BALANCE CARRIED
TO THE B/S |
127.953 |
111.453 |
164.060 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
5.85
|
1.31 |
12.18 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA |
NA |
NA |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
NA |
NA |
NA |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
NA |
NA |
NA |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.44
|
1.11 |
1.20 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.04
|
1.39 |
1.35 |
LOCAL AGENCY FURTHER INFORMATION
|
Check
List by Info Agents |
Available
in Report (Yes / No) |
|
1)
Year of Establishment |
Yes |
|
2)
Locality of the firm |
Yes |
|
3)
Constitutions of the firm |
Yes |
|
4)
Premises details |
No |
|
5)
Type of Business |
Yes |
|
6)
Line of Business |
Yes |
|
7)
Promoter's background |
Yes |
|
8)
No. of employees |
No |
|
9)
Name of person contacted |
No |
|
10)
Designation of contact person |
No |
|
11)
Turnover of firm for last three years |
Yes |
|
12)
Profitability for last three years |
Yes |
|
13)
Reasons for variation <> 20% |
-- |
|
14)
Estimation for coming financial year |
No |
|
15)
Capital in the business |
Yes |
|
16)
Details of sister concerns |
Yes |
|
17)
Major suppliers |
No |
|
18)
Major customers |
No |
|
19)
Payments terms |
No |
|
20)
Export / Import details (if applicable) |
No |
|
21)
Market information |
-- |
|
22)
Litigations that the firm / promoter involved in |
-- |
|
23)
Banking Details |
Yes |
|
24)
Banking facility details |
Yes |
|
25)
Conduct of the banking account |
-- |
|
26)
Buyer visit details |
-- |
|
27)
Financials, if provided |
Yes |
|
28)
Incorporation details, if applicable |
Yes |
|
29)
Last accounts filed at ROC |
Yes |
|
30)
Major Shareholders, if available |
Yes |
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.34 |
|
|
1 |
Rs.86.55 |
|
Euro |
1 |
Rs.67.95 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
49 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.